Introduction
Bone is a specialized tissue that serves multiple functions, such as structural support, protection of vital organs, and metabolic regulation of mineral balance.
1 Thus, effective treatment or replacement of osseous defects is important in bone tissue engineering.
2 Autologous gras, usually harvested from a patient's own bone, are the ideal materials for bone substitutes because of their osteogenic, osteoinductive, and osteoconductive properties.
3 However, there are many barriers to the use of autologous gras, such as limited availability, requirement of a second surgery, increased operation time, lack of gra quantity, secondary infection or bleeding, chronic donor site pain, and additional preparation cost. 3 To overcome these disadvantages of autologous gras, several bone gra substitutes, such as allogras, xenogras, and alloplasts, are used as lling materials because of their compositional similarity, biocompatibility, and osteoconductivity. [4] [5] [6] Among these bone substitutes, xenogras are commonly used in all elds of orthopedic and dental surgery, based on much evidence for their suitability in in vivo applications.
Clinically, xenogra bone substitutes, such as deproteinized bovine bone mineral (DBBM), are typically used in a hydrated form, mixed with saline or the patient's blood, although these substitute particles are not well agglomerated. Because xenogra bone substitute particles are not well retained at the defect site, their displacement reduces the osteoconductivity before bone formation is properly generated. To date, diverse approaches have been attempted to solve these problems caused by using xenogra particles. [7] [8] [9] [10] [11] [12] One major approach is to employ a physical barrier using non-resorbable materials (e.g., titanium mesh and expanded polytetrauorethylene) or resorbable materials (e.g., collagen membrane, polylactic acid, polyglycolic acid, and polyurethane).
7-10 Although non-resorbable barrier membranes provide an effective barrier function for a sufficient period of time, they require a second surgery for their removal. 7, 9 In contrast, resorbable barrier membranes can be resorbed by the body; however, these membranes have several weaknesses, such as unpredictable degradation time and weak rigidity. 7 Another approach is mixing with sticky biomaterials, such as collagen and hyaluronic acid, without a barrier membrane. 11, 12 Several reports have provided evidence for improved bone regeneration by increasing the retention of xenogra particles by using sticky materials. However, these sticky materials usually lack osteoinductivity and thus should be further investigated to prove their efficacy.
Mussel adhesive proteins (MAPs) have been paid great attention as biomaterials in tissue and biomedical engineering because of their superior properties, including biocompatibility and surface-independent adhesiveness, even in a wet environment.
13,14
Previously, recombinant hybrid-type MAP was designed and mass-produced in Escherichia coli to overcome the limited availability of natural MAPs. 15 This hybrid MAP is composed of six repeats of type 1 protein (fp-1) decapeptide at both the N-and the C-termini of type 5 protein (fp-5). In general, the outstanding adhesive properties of MAPs are attributed to 3,4-dihydroxyphenylalanine (DOPA), which is the hydroxylated form of tyrosine. 16 Aside from its adhesive role as a protein constituent, several reports show that the DOPA molecule shows osteoinductive activity in vitro [17] [18] [19] and in vivo.
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In the present work, we evaluated the in vivo potential of MAP as a functional osteoinductive binder material for bone regeneration in bone tissue engineering. We conrmed both the binding of DOPA-containing MAP (mMAP) to DBBM particles and the effects of mMAP-bound DBBM on new bone formation in a defect in the rat calvaria. We also investigated several in vitro cellular behaviors, such as adhesion, proliferation, spreading, and differentiation, on an mMAP-coated surface to assess the osteoinductive ability of mMAP.
Experimental

Preparation of mMAP
The expression and purication of a recombinant hybrid-type MAP, fp-151, were performed as described in previous studies. 15, [21] [22] [23] For in vitro DOPA modication, 2 g L À1 of puried original MAP was dissolved in 200 mM acetate buffer (pH 5.5) with 20 mM ascorbic acid and 20 mM boric acid. Mushroom tyrosinase (Sigma-Aldrich, St. Louis, MO) was then added to the solution to a nal concentration of 50 mg L
À1
. The modication reaction was performed at room temperature for 1 h under gentle stirring and aeration. DOPA conversion of tyrosine residues was assessed by nitroblue tetrazolium (NBT) staining and amino acid composition analysis as followed in previous studies. 23, 24 The mMAP was freeze dried for further procedures.
NBT staining
Quinone-carrying quinoproteins and quinonoid substances such as DOPA and DOPA-quinone are detectable by redoxcycling staining in the presence of NBT and glycinate at alkaline pH. Aer gel electrophoresis of mMAP which was dissolved in 5% (vol/vol) acetic acid, the gel was transferred to a nitrocellulose membrane (Protan BA83; Whatman, GE healthcare, Little Chalfont, UK). Then, the membrane was immersed in 2 M sodium glycinate buffer (pH 10) containing 0.5 mg ml À1 NBT and incubated at room temperature until a blue-purple color developed. The stained membrane was washed with 0.2 M sodium borate solution (pH 8.5) and DW.
Amino acid composition analysis mMAP was hydrolyzed into amino acids using the ninhydrin reaction. mMAP was placed in a glass vial and dissolved in a 20 : 1 mixture of 6 M HCl with phenol. The glass vial was sealed aer being charged with Argon gas. mMAP was hydrolyzed at 156 C for 1 h, then, its hydrolysate was evaporated and washed to remove the solvent. Aer dissolving the hydrolyzed mMAP in a dilution buffer, content values of its amino acids including DOPA were determined using an amino acid analyzer (S4300, SYKAM, Germany) and recalculated to nd the ratio of DOPA in mMAP.
Preparation of DBBM aggregate using mMAP binder DBBM (Ti-Oss; Chiyewon, Guri, Korea) was used as an experimental xenogra bone substitute material for in vivo bone regeneration. mMAP powder was dissolved in endotoxin-free distilled water (HyClone, Logan, UT) to a 300 g L À1 concentration. The protein sample was stored in a vacuum-packed state and opened at the time of its use. In total, 10 mg of DBBM particles were mixed with 100 mL of mMAP solution to prepare the DBBM aggregate. To investigate the morphology of osteoblast cells on the DBBM surface, 50 mg of mMAP per cm 2 of well area was coated to the DBBM particle using the precipitation method as followed in a previous study. 21 Then, osteoblast MC3T3-E1 cells (RIKEN Cell Bank, Tsukuba, Japan) were seeded on DBBM alone and on mMAP-coated DBBM samples. Aer 1 day of cultivation under serum-containing conditions, the morphology of the osteoblast cells on the DBBM surfaces was analyzed by scanning electron microscopy (SEM; JSM-6010LV; JEOL Ltd., Tokyo, Japan) using 5 kV secondary electron imaging.
Animal surgery for in vivo bone regeneration
Fieen male Sprague-Dawley rats (Orient Bio Inc., Gyeonggido, Korea) weighing $250-300 g were housed two per cage in a facility of the specic-pathogen-free-2 (SPF-2) level, which was covered with so bedding. The rats were allowed free access to food and water in a temperature-and humidity-controlled room (23 C, 50%) with a 12/12 h day/night cycle (8 am/8 pm). Aer a 7 day acclimation, each rat was anesthetized with an intramuscular injection of 30 mg kg À1 Zoletil 50 (tiletamine and zolazepam; Virbac, Carros, France) and 10 mg kg À1 Rompun (xylazine; Bayer, Leverkusen, Germany), and the scalp was incised carefully. Each exposed calvaria was then punctured in a critical size of defect using an 8 mm-diameter trephine bur under sterile saline irrigation, and the hole was lled with 10 mg of Ti-Oss aggregate containing 100 mL of mMAP. The defect area in the negative-control (sham surgery) group was le empty, whereas that of the DBBM group was lled with only 10 mg of Ti-Oss particles. The incised periosteum and skin were closed in layers with 5-0 Vicryl sutures (Ethicon, Somerville, NJ) aer the procedure. Aer the surgery, the rats were kept in their cages for 8 weeks. To obtain calvarial samples for radiographic and histological analyses, the rats were sacriced using the formalin-perfusion xation method.
Radiographic and histological analyses for in vivo bone regeneration
The rat calvarial specimens were xed with 10% formalin for 24 h. Radiographs of the specimens were then taken using X-ray microtomography (mCT) (SkyScan 1172; Bruker-microCT, Kontich, Belgium). A total of 683 slices were imaged (10.89 mm per slice for a 590 ms exposure) for each specimen, and the pictures were analyzed and used to generate a 3D image of 2000 Â 1048 pixels using CT reconstruction soware (NRecon v.1.4.4; Bruker-microCT). The regenerated bone area was quantied using an image analysis program (CTAn v.1.6.0; BrukermicroCT).
Aer radiographic analysis, the rat calvarial specimens were decalcied in a decal solution (Calci-Clear Rapid; National Diagnostics, Atlanta, GA) for 24 h. The samples were then embedded in paraffin and cut into 3 mm sections. The tissue slices were subjected to deparaffinization and hydration steps and then stained with hematoxylin-eosin (H&E; Sigma-Aldrich), Masson trichrome (MT; Sigma-Aldrich), and toluidine blue (TB; Sigma-Aldrich). Histologic photographs were taken under a BX-41 microscope (Olympus, Tokyo, Japan) and analyzed using ToupView soware (ToupTek Photonics Co., Hangzhou, China).
In vitro cell attachment and proliferation analyses
Six-or 24-well polystyrene culture plates (SPL Life Sciences, Pocheon, Korea) were used for the in vitro studies. In total, 50 mg of MAP per cm 2 of well area was used for surface coating, and the coating method was performed according to a previous study. 21 A surface coated with PLL (Sigma-Aldrich) was used as a comparative control, and an uncoated, bare surface was used as a negative control. PLL was coated onto culture plates as described in the manufacturer's instructions.
MC3T3-E1 osteoblast cells were maintained in Minimal Essential Medium-alpha (a-MEM; HyClone) supplemented with 10% (vol/vol) fetal bovine serum (FBS; HyClone) and penicillin/ streptomycin (HyClone) at 37 C under 5% CO 2 in a humid
atmosphere. The cells were subcultured using 0.05% trypsinethylenediaminetetraacetic acid (trypsin-EDTA; HyClone) when they reached 80% conuence. For cell attachment testing, 5 Â 10 4 cells (>95% viable) in serum-free medium were pipetted onto each sample-coated 24-well culture plate. The cells were incubated in a humidied incubator (37 C and 5% CO 2 ) for 1 h, allowing them to adhere to the sample-coated culture plates, and unattached or loosely tethered cells were removed from the surfaces using Dulbecco's modied phosphate-buffered saline (DPBS; HyClone). The attached cells on the surface were further cultured in culture medium for 72 h for a proliferation experiment. A Cell Counting Kit-8 (CCK-8; Dojindo Laboratories, Kumamoto, Japan) was used to quantify cell attachment and proliferation. The CCK-8 assay was performed aer the cell attachment experiment and every 24 h for 3 days. A total of 25 mL of the CCK-8 solution was added to each well, and the plates were further incubated for 3 h at 37 C. Aer incubation, the formazan-containing media were transferred to a 96-well plate (SPL Life Sciences) and measured at 450 nm using a microplate absorbance spectrophotometer (Bio-Rad, Hercules, CA).
In vitro cell spreading and cytoskeletal organization analyses MC3T3-E1 cells were cultured in serum-free medium for serum starvation before the cell spreading experiment. In total, 1 Â 10 5 cells in serum-free medium were placed in a sample-coated 12 mm f cover glass (Superior Marienfeld, Lauda-Königshofen, Germany) and incubated for up to 18 h. FITC-conjugated phalloidin (Sigma-Aldrich) and 4 0 ,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) were used to stain actin laments and nuclei, respectively. The specimens were analyzed using a uorescence microscope (Olympus, Tokyo, Japan).
In vitro cell differentiation analyses
MC3T3-E1 cells were seeded into sample-coated 6-well plates and cultured in the same way as in the proliferation experiment. At 90% conuence, differentiation of the osteoblast cells was induced by differentiation medium, which was a mixture of 50 mg mL À1 ascorbic acid, 10 mM sodium phosphate monobasic, and 1 nM dexamethasone (Sigma-Aldrich) in culture medium. The mineralized matrix of the MC3T3-E1 cells at 21 days aer differentiation was stained with Alizarin Red S solution (adjusted to pH 4.2 with ammonium hydroxide; Sigma-Aldrich) aer formaldehyde xation. Aer the removal of the Alizarin Red S solution, the cells were rinsed three times with deionized water. Images of the stained area were obtained using an optical microscope (Olympus).
To evaluate osteogenic gene expression, total RNA was isolated from cells at 7 days aer differentiation using the TRIzol® reagent (Invitrogen, Carlsbad, CA) following the manufacturer's protocol. The total RNA was quantied by absorbance readings at 260 nm using a UV-Vis spectrophotometer (Mecasys, Daejeon, Korea). Following RNA purication, rst-strand cDNA was synthesized from 1 mg of total RNA using TOPscript™ RT Dry-MIX (dT18) (Enzynomics, Daejeon, Korea). Real-time RT-PCR analysis was performed using a thermocycler (LightCycler® 2.0; Roche Applied Science, Basel, Switzerland). Samples (2 Â SYBR Green Mix, 0.5 mM each appropriate primer, and cDNA) were amplied in the thermocycler for an initial denaturation at 95 C for 15 min, followed by 40 PCR cycles. Each cycle consisted of 95 C for 15 s, 60 C for 30 s, and 72 C for 30 s. The oligonucleotide primers for the experiment are shown in Table  1 . The amplied target gene was rst detected at a specic uorescence intensity (Ct, cycle threshold), and data were generated by relative quantication normalized to the housekeeping gene. Briey, 3 independently tested Ct values of the target gene were normalized to those of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene for computation of DCt, and calculation of DDCt was then performed by subtracting the DCt value of the control group from that of the test group. The fold change in target gene expression in the test group was calculated by the comparative Ct method. 25 To check for amplication error, a melting-curve analysis (cooling the sample to 65 C for 15 s and then heating slowly to 95 C, with continuous measurement of uorescence) was immediately performed at the end of each PCR.
Statistical analysis
In vivo data were obtained from 3 (for sham surgery) or 6 (for the DBBM-alone and mMAP-bound DBBM groups) individual rats. Independent in vitro experiments were performed at least 3 times, and triplicate samples were analyzed in each experiment. The signicance of the data obtained from the control and test groups was statistically analyzed using the one-way analysis of variance (ANOVA) test. A p-value of <0.05 was considered statistically signicant.
Results and discussion
DOPA modication of MAP and binding of DBBM particles using mMAP
Due to the absence of post-translational modication machinery in an E. coli system, we performed in vitro DOPA modication using mushroom tyrosinase. Based on the NBT staining, we observed the appearance of a purple band for tyrosinase-treated MAP, whereas no band was observed for the unmodied original sample, indicating successful in vitro DOPA modication (Fig. 1A) .
To quantify the DOPA modication yield, we analyzed the amino acid composition of mMAP using a chromatographic method, even though the calculation of the precise yield might have been impossible due to the hydrolysis step during sample preparation. We determined that the in vitro percentage of conversion (modication yield) of tyrosine residues to DOPA molecules was $38.2% by amino acid composition analysis (Fig. 1B) .
To test the binding ability of mMAP in aqueous environments, we prepared the DBBM particles and mMAP to make an aggregate, and compared with the unmodied MAP/DBBM aggregate. We observed that each DBBM particle was easily agglomerated to form a large cluster in the mMAP-treated group (Fig. 2A) . Moreover, the DBBM aggregate was not separated into particles when it was lied by forceps (data not shown), indicating that mMAP effectively binds bone substitute particles. Even though both aggregates of mMAP/DBBM and MAP/DBBM had almost a similar appearance in dry environments, the MAP/ DBBM aggregate rapidly dispersed in aqueous environments ( Fig. 2A) .
Next, prior to the animal experiment, in vitro osteoblast MC3T3-E1 cell adhesion to the mMAP-applied DBBM surface was evaluated. We found that both cell spreading on and the population of the mMAP-applied DBBM were more extensive than on the DBBM alone (Fig. 2B) .
In vivo bone regeneration using mMAP-bound DBBM aggregates
Depending on the applied body parts, in vivo applications oen should maintain their performance in aqueous environments such as blood and body uid. MAP without DOPA modication may not sustain its adhesive capability during the in vivo regeneration period. Therefore, we conducted in vivo bone regeneration in a critical-sized rat calvarial defect model using the mMAP-bound DBBM aggregate. A sham surgery group was used as a negative control, and a DBBM-alone group was used as a comparative control. The rats were sacriced aer 8 weeks of healing for radiographic and histological analyses. Visualization and quantication of newly formed bone in the criticalsized rat calvarial defect were performed via a mCT system. Although mCT is powerful technique for the assessment of bone tissue, it is difficult to distinguish a newly formed bone from graed DBBM due to their compositional similarity. Furthermore, it is known that DBBMs (e.g., Bio-Oss and Ti-Oss) are hardly resorbed during the experimental period. 26 Therefore, mCT analysis was conducted based on density differences to distinguish the newly formed bone from the graed DBBM. Images of the transverse plane (Fig. 3A-a) and sagittal plane (Fig. 3A-b) and a 3-dimensional (3D) bone scan (Fig. 3A-c) showed that the defect (white dotted circle in Fig. 3A-a) signicantly recovered, forming a new bone, in the DBBM-alone and mMAP-bound DBBM groups.
Whereas the bone defect of the sham surgery group was only $13% repaired, the percentage of bone volume per tissue volume in the DBBM-alone group increased by more than $45% during the 8 weeks of healing (Fig. 3B) . Importantly, the total amount of newly formed bone in the mMAP-bound DBBM group signicantly increased, up to $57% (Fig. 3B) . Notably, we observed a signicant loss of DBBM particles from the detect site in the DBBM-alone group (yellow dotted circle in Fig. 3A-a) . Therefore, from these radiographic analyses, we could conclude that the superior in vivo bone regeneration effect of mMAP was attributable to the adhesive nature of MAP, binding DBBM particles in the desired location (the defect site) and possibly recruiting endogenous functional biomolecules to the surface of the DBBM. Furthermore, interestingly, in the rat calvarial defect site, a new bone formed more densely in the mMAPbound DBBM group compared with the DBBM-only group and had a similar density to the normal bone (Fig. 3C) . This result might indicate that mMAP has an osteoinductive function in in vivo bone maturation.
Aer quantication of bone regeneration, we evaluated the quality of the newly formed bone by 3 staining methods: H&E, MT, and TB staining. Similar to the results of the radiographic analysis, a larger amount of bone formation was clearly observed in the mMAP-bound DBBM group compared with the DBBM-only group by H&E staining (40 Â magnication; Fig. 4C ), newly formed lamellar bone (yellow arrows) resulting from osteoblastic osteoid formation and osteoid (blue arrows) resulting from osteoblast rimming (white arrows) were detected in the mMAP-bound DBBM group, whereas osteoid from osteoblast rimming was found only adjacent to the DBBM in the DBBM-only group. Furthermore, we observed osteocytes (red arrows) only in the mMAP-bound DBBM group (Fig. 4C) . These results indicate that the new bone created between the DBBM particles had already formed before the eighth week of healing and that the bone remodeling process was actively progressing in the mMAP-bound DBBM group.
The terminology of 'osteoinductive activity' was originally dened as the procedure in which osteogenesis is induced.
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Recently, it is considered that the osteoinduction process is composed of 3 sequential processes; cell/active molecule recruit, cell differentiation, and bone formation. 29 We suggest that mMAP has osteoinductive activity based on recruitment of cells and active molecules through its unique adhesion ability even though it does not possess autoinduction properties such as BMP-2. Consequently, in vivo bone regeneration was accelerated by mMAP, and subsequently, the bone remodeling process was stimulated in the mMAP-bound DBBM group. Because mMAP can assist bone regeneration in both quantitative and qualitative aspects in the rat calvarial defect model, it could be successfully utilized as a functional biomaterial for bone tissue engineering.
In vitro osteoblast cell behaviors on the mMAP-coated culture surface. Based on the in vivo bone regeneration experiments, we found that mMAP might have osteoinductive ability. Thus, to evaluate the potency of the osteoinductivity of mMAP, we investigated in vitro osteoblast cell behaviors (attachment, proliferation, spreading, and differentiation) on MAP (with or without DOPA)-coated surfaces. An uncoated, bare surface was used as a negative control, and a poly-L-lysine (PLL)-coated surface was used as a positive control because the isoelectric point (pI) ($9.74) of PLL is similar to the calculated value ($9.91) for MAP. 15 The rst stage in the process of cell-surface interaction is the cell attachment, which can affect subsequent cellular responses, such as spreading, proliferation, and differentiation. 30 All cell attachment tests were performed under serum-free conditions to minimize the effects of the diverse adhesion factors in the serum. Although cell attachment was slightly increased on the mMAP-coated surface compared with that of the bare surface, there was no difference from the unmodied MAP-coated surface (Fig. 5A) .
Proliferation levels on all sample-coated surfaces showed an at least 2-fold increase compared with the bare surface (Fig. 5B) . However, there was also no difference in osteoblast proliferation between the mMAP-and the unmodied MAP-coated surfaces. These results might indicate that the DOPA residues in mMAP do not contribute to cell attachment and proliferation.
Because proliferation levels on all MAP-coated surfaces were increased ($12%), regardless of DOPA existence, compared with levels on the PLL-coated surface (Fig. 5B) , we can conclude that a MAP-coated surface provides a more favorable environment for osteoblast cell proliferation through its adhesive ability and/or accumulation of positively charged ions (e.g., Ca 2+ ) on the coated surface 31,32 by p-cation interaction using its rich aromatic amino acid residues.
33,34
From a morphological perspective, one of the regulating factors for cell fate is the degree of cell spreading. 35 To examine the effect of mMAP coating on cell spreading, we monitored the morphological changes of MC3T3-E1 cells on the sample-coated surfaces under serum-free conditions using immunocytochemical analysis with uorescein isothiocyanate (FITC)-conjugated phalloidin staining. In low-resolution spreading images, more osteoblast cells were attached on both unmodied MAP-and mMAP-coated surfaces than in the comparative groups (Fig. 5C) . Furthermore, we observed that cell spreading on both MAP-and mMAP-coated surfaces was more stretched than spreading in the control groups in high-resolution images (inset image in Fig. 5C ). It is known that the cell spreading event typically occurs through interaction of extracellular matrix (ECM) proteins (or their specic peptides) and their receptors. 36, 37 Several studies, however, have demonstrated that osteoblast cell spreading can also be inuenced by immobilized calcium ions. 38, 39 Because our experimental samples did not have any activating groups for cell spreading, such as ECM proteins or their specic peptides, we suspect that calcium ions attached to MAP via p-cation interaction fostered a better spreading environment than in the other control groups under serum-depleted conditions.
Aer the period of cell proliferation, the ECM of osteoblast cells undergoes compositional and organizational adaptation for mineralization. 40 Although these changes are typically induced by growth factors and hormones, especially bone morphogenetic protein-2 (BMP-2), the differentiation of osteoblast cells can be also induced in DOPA-contained environments. [17] [18] [19] [20] To evaluate the effect of the DOPA residues in mMAP, we examined the differentiation of MC3T3-E1 cells on samplecoated surfaces. Phenotypic osteoblast differentiation was assessed by measuring the calcium deposition of the ECM of differentiated MC3T3-E1 cells through visualization using Alizarin Red S staining. We observed that the mineral deposition of MC3T3-E1 cells on the mMAP-coated surface was signicantly increased compared with deposition on bare and PLL-coated surfaces (Fig. 6A) .
Although mineral deposition on the unmodied MAP-coated surface was lower than that on the mMAP-coated surface, this deposition occurred at a much higher level than in the control groups. Thus, similar to previous results on proliferation and spreading, we strongly suggest that the increased calcication was seriously affected by MAP via its adhesive ability and/or electrostatic interaction. Next, genotypic differentiation was determined by the quantication of the expression levels of osteogenic genes, including runt-related transcription factor 2 (Runx2), type 1 collagen (T1Col), bone sialoprotein (BSP), alkaline phosphatase (ALP), and osteocalcin (OCN), using the realtime reverse transcription-polymerase chain reaction (RT-PCR). We found that the expression of all of the transcription factor . MC3T3-E1 cells were incubated in sample-coated 24-well polystyrene culture plates for 1 h for cell attachment. The viable cells attached to the surface were measured by a colorimetric assay. The values and error bars represent the means of three independent experiments with triplicate samples and standard deviations, respectively, with statistical significance (*p < 0.05, **p < 0.01, ***p < 0.005, one-way ANOVA). For the spreading test, cells were added to a cover glass coated with 50 mg cm À2 of sample without serum and cultured for 18 h. Actin filaments stained with FITC-phalloidin are presented in green, and nuclei stained with DAPI are blue. The scale bars represent 50 mm. Abbreviations: NC, bare surface; MAP, unmodified MAP-coated surface; mMAP, DOPA-containing MAP-coated surface; PLL, poly-L-lysine-coated surface.
and marker genes related to osteoblast differentiation was signicantly increased in cells on both MAP-and mMAP-coated surfaces compared with a bare surface (Fig. 6B) . Interestingly, BSP gene expression was remarkably upregulated on the mMAPcoated surface compared with the unmodied MAP-coated surface. Because it is known that BSP is involved in the mineralization process of osteoblast cells and their maturation, 41, 42 we assumed that the DOPA residues in mMAP are closely related to the maturation of osteoblast cells. From these results, we conclude that osteoblast differentiation can be induced by MAP and that the effect might be further enhanced by the DOPA residues in mMAP.
Conclusions
Here, we assessed mMAP as a functional osteoinductive binder of DBBM particles for in vivo bone regeneration. DBBM particles agglomerated to form a large cluster aer mixing with a mMAP solution. No loss of graed DBBM particles was observed in a rat calvarial defect during in vivo healing. New bone formation was signicantly improved through graing of the mMAPbound DBBM aggregate compared with DBBM alone ($12% increase) or the sham surgery control ($44% increase). In addition, a new mature bone that had a similar density to the normal bone was formed. Furthermore, the bone remodeling process was accelerated in the mMAP-bound DBBM group. The in vitro osteogenic differentiation of osteoblast cells on the mMAP-coated surface was upregulated overall compared with differentiation on the unmodied MAP-coated surface. Thus, based on the in vivo and in vitro results, we concluded that the DOPA-containing mMAP has good osteoinductive ability. In conclusion, mMAP can be successfully used as a functional osteoinductive binder for bone substitute-assisted in vivo bone regeneration and could be further utilized in other bone tissue engineering applications.
